Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYSTINDO study of vascularization of the vaginal cuff after total laparoscopic hysterectomy using indocyanine green
2024-511467-28-00Phase 4Authorised
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jul 2024
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Infracyanine, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Planned start Jul 2024; status: authorised.
02
Drugs
Infracyanine
Beyond the preview
Go deeper on 2024-511467-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511467-28-00.